Probiotec Limited (ASX:PBP)

Wesley Stringer
CEO
Market Cap (AUD): 190.67M
Sector: Health Care
Last Trade (AUD): 2.4 -0.03 (-1.23%)
Tab Bar

1. About

Probiotec (ASX:PBP) is as a leading manufacturer, marketer and distributor of a diverse, high quality range of prescription and over-the-counter (OTC) pharmaceuticals, complementary medicines and consumer health products.

Probiotec has built an enviable reputation for developing innovative new pharmaceutical, nutraceutical and cosmeceutical products which not only address researched consumer needs, but also succeed in gaining the clinical approvals necessary to respond rapidly to market opportunities, both domestically and internationally.

What separates Probiotec from other trusted contract manufacturers is that it invests heavily in Research and Development, equip its production facilities with the latest new technologies, employ chemists and microbiologists of the highest calibre and maintain Quality Assurance standards that are second to none.

The company also has an intimate understanding of the process and dynamics of developing formulations (and brands) for the retail market that deliver margins that optimise return-on-investment.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk